April 11, 2026 BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer
April 11, 2026 ‘The Charm of Chunhyang Captivates the World’ 96th Namwon Chunhyang Festiva Kicks Off on April 30
April 11, 2026 Highst Urology Clinic Designated as Global Training Center for MegaDerm and ZettaDerm Technology
